Update on biologic safety for patients with psoriasis during pregnancy by Martina L. Porter, Stephen J. Lockwood, Alexa B. Kimball

Connect to this object online.

TNF-α inhibitors in the treatment of hidradenitis suppurativa by Kevin T. Savage, Kelsey S. Flood, Martina L. Porter, Alexa B. Kimball

Connect to this object online.

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded... by Simon J. Gunter, MPhil, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis by Gil Yosipovitch, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, Alexa B. Kimball

Connect to this object online.

Career satisfaction of leaders in academic dermatology: Results from a national survey, by Mona Sadeghpour, MD, Sarah M. Sung, MD, Heidi Jacobe, MD, MSCS, Alexa B. Kimball, MD, MPH

Connect to this object online.

Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study by Ruby S. Gibson, MD, Corey L. Snyder, BSA, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study by Diana S. Kim, BA, Nicole Giannotti, BS, Prerna Salian, MPH, Alexa B. Kimball, MD, MPH, Martina L. Porter, MD

Connect to this object online.

Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis by Charlotte Greif, MD, Ruby S. Gibson, MD, Alexa B. Kimball, MD, MPH, Zachary E. Holcomb, MD, Martina L. Porter, MD

Connect to this object online.

Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review by Corey L. Snyder, MD, Ruby S. Gibson, MD, Stella X. Chen, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes by Alexa B. Kimball, Joslyn Kirby, John R. Ingram, Tanja Tran, Ingrid Pansar, Valerie Ciaravino, Damon Willems, Anne-Mary, Vanita Tongbram, Amit Garg

Connect to this object online.

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients by Kevin T. Savage, BA, Monica Rosales Santillan, MD, Kelsey S. Flood, MD, Alexandra Charrow, MD, MBE, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial by Alexa B. Kimball, Errol P. Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, Ziqian Geng, Tianyu Zhan, Izabella Messina, Falk G. Bechara

Connect to this object online.

Challenges for dermatologists during the COVID-19 pandemic: A qualitative study by Matthew F. Helm, MD, Alexa B. Kimball, MD, MPH, Melissa Butt, MPH, Heather Stuckey, MEd, DEd, Heather Costigan, BS, Kanade Shinkai, MD, PhD, Arielle R. Nagler, MD

Connect to this object online.

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study by Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-, Bruno Martins, Eric Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober

Connect to this object online.

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities by Peyton C. Morss-Walton, BA, Charlotte Greif, BA, Zachary E. Holcomb, MD, Prerna Salian, MPH, Tuyen Yankama, MPH, Diana Kim, BA, Martina L., Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa by Kevin T. Savage, BA, Elena Gonzalez Brant, MD, Monica Rosales Santillan, MD, Peyton C. Morss, BA, Prerna Salian, MPH, Kelsey S. Flood, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk by C. Elise Kleyn, Peter S. Talbot, Nehal N. Mehta, Francesca Sampogna, Chris Bundy, Darren M. Ashcroft, Alexa B. Kimball, Peter C.M. van de Kerkhof, Christopher E.M. Griffiths, Fernando Valenzuela, Joelle M. van der Walt, Tsion Aberra, Lluís Puig

Connect to this object online.

Clinical Goals and Barriers to Effective Psoriasis Care by Bruce E. Strober, Joelle M. van der Walt, April W. Armstrong, Marc Bourcier, Andre V. E. Carvalho, Edgardo Chouela, Arnon D. Cohen, Claudia de la Cruz, Charles N. Ellis, Andrew Y. Finlay, Alice B. Gottlieb, Johann E. Gudjonsson, Lars Iversen, C. Elise Kleyn, Craig L. Leonardi, Charles W. Lynde, Caitriona Ryan, Colin T. Theng, Fernando Valenzuela, Ronald Vender, Jashin J. Wu, Helen S. Young, Alexa B. Kimball

Connect to this object online.